BIOMAT Database Logo BIOMAT Database Logo

[Algorithms of mono- and polytherapy in clinical epileptology]. 2016

V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
Evdokimov Moscow State Medical and Dentistry University, Moscow, Russia.

The large number of antiepileptic drugs (AEDs) at the physician's disposal provides not only a broad therapeutic potential in the treatment of epilepsy (EP), but creates difficulties in the adequate choice of AED. The sufficient experience in the management of patients with epilepsy has been gained so far in the world, based on which the International League Against Epilepsy (ILAE), updated classification, adopted the basic definition of efficiency, remission, resistance, evidence of research on the effectiveness of AED therapy, and introduced the concept of "resolved" epilepsy. In this article, a group of Russian experts suggest recommendations on the main steps in the choice of therapy in epilepsy. Possible drug interactions between different AEDs and other drugs as well as main characteristics of mono- and polytherapy of epilepsy are described. Some features of the use of AEDs in the elderly, characteristics of the "female" epilepsy related to the reproductive function and basic requirements for the therapy of epilepsy in children are presented.

UI MeSH Term Description Entries
D010820 Physicians Individuals licensed to practice medicine. Physician
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
[Mono- or polytherapy of epilepsy?].
August 1984, Wiener klinische Wochenschrift,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
Mono- or polytherapy and the severity of epilepsies.
September 1988, The Japanese journal of psychiatry and neurology,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
[Mono- or polytherapy in the treatment of epileptic patients].
January 1983, Minerva medica,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
Self reported adverse effects of mono and polytherapy for epilepsy.
October 2012, Seizure,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
[Magnetoencephalography in clinical epileptology].
April 1992, No to shinkei = Brain and nerve,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
[Advances in clinical epileptology].
September 1991, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
September 2015, Neurology,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
[Blood level of antiepileptic drugs and therapeutic effect in mono- and polytherapy (author's transl)].
November 1978, Der Nervenarzt,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
[Determination of antiepileptic serum levels in patients with mono- and polytherapy in correlation with the clinical picture of the disease].
January 1985, Medicinski arhiv,
V A Karlov, and A B Guekht, and V I Guzeva, and L V Lipatova, and S N Bazilevich, and V R Mkrtchyan, and P N Vlasov, and I A Zhidkova, and K Yu Mukhin, and A S Petrukhin, and A V Lebedeva
A model for the determination of carbamazepine clearance in children on mono- and polytherapy.
June 1998, European journal of clinical pharmacology,
Copied contents to your clipboard!